Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
5.31
-0.12 (-2.21%)
Apr 9, 2026, 11:39 AM CST
SHE:000597 Revenue
In the year 2025, Northeast Pharmaceutical Group had annual revenue of 7.07B CNY, down -5.70%. Northeast Pharmaceutical Group had revenue of 1.60B in the quarter ending December 31, 2025, with 16.63% growth.
Revenue
7.07B
Revenue Growth
-5.70%
P/S Ratio
1.10
Revenue / Employee
1.19M
Employees
5,964
Market Cap
7.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.07B | -427.70M | -5.70% |
| Dec 31, 2024 | 7.50B | -740.62M | -8.98% |
| Dec 31, 2023 | 8.24B | -565.77M | -6.42% |
| Jan 1, 2023 | 8.81B | 663.83M | 8.15% |
| Dec 31, 2021 | 8.15B | 760.76M | 10.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 2.23B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.52B |
| Hunan Er-Kang Pharmaceutical | 1.29B |
| Zhejiang Garden Biopharmaceutical | 1.24B |